Equities

Idex Biometrics ASA

Idex Biometrics ASA

Actions
IndustrialsElectronic and Electrical Equipment
  • Price (NOK)0.1265
  • Today's Change-0.001 / -1.02%
  • Shares traded4.33m
  • 1 Year change-94.86%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

Idex Biometrics ASA (IDEX:OSL) set a new 52-week low during Thursday's trading session when it reached 0.125. Over this period, the share price is down -94.45%.
52-week range
Today
0.125Nov 21 20243.23Nov 29 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.1329
High0.1329
Low0.125
Bid0.1265
Offer0.136
Previous close0.1278
Average volume10.03m
Shares outstanding945.42m
Free float786.13m
P/E (TTM)--
Market cap119.89m NOK
EPS (TTM)-0.614
NOK
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.